LivaNova’s programming algorithm boosts response rates in sleep apnoea patients

LivaNova’s proprietary PolySync algorithm allows for proximal hypoglossal nerve stimulation (p-HGNS) stimulation fields to be reconfigured. LivaNova’s proprietary PolySync algorithm allows for proximal hypoglossal nerve stimulation (p-HGNS) stimulation fields to be reconfigured. With a PMA from the FDA in hand, LiveNova is targeting a US market launch of its aura6000 system in 2027. Credit: mariakray / Shutterstock.com New data from LivaNova has demonstrated the clinical benefit of its programming algorithm in patients with obstructive sleep apnoea (OSA). Trial data demonstrated that the company’s PolySync programming algorithm increased the response rate for OSA patients undergoing proximal hypoglossal nerve stimulation (p-HGNS) treatment…

Source: Medical Device Network